SHL Telemedicine Ltd. (SHLT)
NASDAQ: SHLT · IEX Real-Time Price · USD
5.38
-0.09 (-1.65%)
At close: Apr 22, 2024, 12:00 AM
5.47
+0.09 (1.67%)
After-hours: Apr 22, 2024, 4:00 PM EDT
SHL Telemedicine Market Cap
SHL Telemedicine has a market cap or net worth of $88.19 million as of April 23, 2024. Its market cap has decreased by -50.32% in one year.
Market Cap
88.19M
Enterprise Value
81.79M
1-Year Change
-50.32%
Ranking
Category
Stock Price
$5.38
Market Cap Chart
Since April 6, 2023, SHL Telemedicine's market cap has decreased from $349.00M to $88.19M, a decrease of -74.73%. That is a compound annual growth rate of -73.14%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 22, 2024 | 88.20M | 4.50% |
Apr 19, 2024 | 84.40M | 0.96% |
Apr 18, 2024 | 83.60M | -1.53% |
Apr 17, 2024 | 84.90M | 2.54% |
Apr 16, 2024 | 82.80M | -9.41% |
Apr 15, 2024 | 91.40M | - |
Apr 12, 2024 | 91.40M | -4.19% |
Apr 11, 2024 | 95.40M | -4.22% |
Apr 10, 2024 | 99.60M | 8.14% |
Apr 9, 2024 | 92.10M | -3.05% |
Apr 8, 2024 | 95.00M | 1.17% |
Apr 5, 2024 | 93.90M | -8.48% |
Apr 4, 2024 | 102.60M | 6.99% |
Apr 3, 2024 | 95.90M | -7.07% |
Apr 2, 2024 | 103.20M | -6.01% |
Apr 1, 2024 | 109.80M | 9.80% |
Mar 28, 2024 | 100.00M | -1.57% |
Mar 27, 2024 | 101.60M | -5.22% |
Mar 26, 2024 | 107.20M | 8.50% |
Mar 25, 2024 | 98.80M | -0.20% |
Mar 22, 2024 | 99.00M | -3.79% |
Mar 21, 2024 | 102.90M | - |
Mar 20, 2024 | 102.90M | 0.78% |
Mar 19, 2024 | 102.10M | -1.07% |
Mar 18, 2024 | 103.20M | - |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Elicio Therapeutics | 85.86M |
AlloVir | 85.57M |
111, Inc. | 85.19M |
Connect Biopharma Holdings | 84.86M |
Seres Therapeutics | 84.55M |
Curis | 84.34M |
Reviva Pharmaceuticals Holdings | 84.31M |
CEL-SCI | 84.21M |